控制退伍军人事务部内部的肿瘤药物成本：全国视角
Controlling the Cost of Oncology Drugs Within the VA: A National Perspective.
作者信息
Heron Bernadette B, Geraci Mark C
机构信息
and are both National Pharmacy Benefits Management Clinical Pharmacy Program Managers in the VA Pharmacy Benefits Management Services Division.
出版信息
Fed Pract. 2015 Jan;32(Suppl 1):16S-20S.
Abstract
The VA Pharmacy Benefits Management Service has developed a number of tools and procedures to provide treatment guidance, increase consistency, and minimize costs across all VA facilities.
摘要
美国退伍军人事务部药房福利管理服务处已开发出一系列工具和程序，以提供治疗指导、提高一致性并使所有退伍军人事务部设施的成本降至最低。
相似文献
1
Controlling the Cost of Oncology Drugs Within the VA: A National Perspective.控制退伍军人事务部内部的肿瘤药物成本：全国视角
Fed Pract. 2015 Jan;32(Suppl 1):16S-20S.
2
The Cost of Oncology Drugs: A Pharmacy Perspective, Part 2.肿瘤药物的成本：药学视角，第二部分。
Fed Pract. 2016 Jul;33(7):35-39.
3
Evaluation of pharmacy services in emergency departments of Veterans Affairs Medical Centers.退伍军人事务医疗中心急诊科药学服务评估
Am J Health Syst Pharm. 2015 Sep 1;72(17 Suppl 2):S110-4. doi: 10.2146/sp150019.
4
Pharmacy data in the VA health care system.美国退伍军人事务部医疗保健系统中的药房数据。
Med Care Res Rev. 2003 Sep;60(3 Suppl):92S-123S. doi: 10.1177/1077558703256726.
5
Pharmacy practice in the Veterans Administration.退伍军人管理局的药学实践。
Am J Hosp Pharm. 1987 Apr;44(4):747-54.
6
Increasing access for veterans with hepatitis C by enhancing use of clinical pharmacy specialists.通过加强临床药学专家的使用，增加丙型肝炎退伍军人的获得途径。
J Am Pharm Assoc (2003). 2019 May-Jun;59(3):398-402. doi: 10.1016/j.japh.2019.01.018. Epub 2019 Mar 8.
7
Methods for estimating and comparing VA outpatient drug benefits with the private sector.评估和比较退伍军人事务部（VA）门诊药物福利与私营部门的方法。
Med Care. 2003 Jun;41(6 Suppl):II61-9. doi: 10.1097/01.MLR.0000068420.29471.F8.
8
Documentation of chemotherapy infusion preparation costs in academic- and community-based oncology practices.学术性和社区肿瘤治疗实践中化疗输注准备成本的记录。
J Natl Compr Canc Netw. 2006 Mar;4(3):197-208. doi: 10.6004/jnccn.2006.0020.
9
The Cost of Oncology Drugs: A Pharmacy Perspective, Part I.肿瘤药物的成本：药学视角，第一部分
Fed Pract. 2016 Feb;33(Suppl 1):22S-25S.
10
Projection of future pharmacy service fees using the dispensing claims in hospital and clinic outpatient pharmacies: national health insurance database between 2006 and 2012.利用医院和诊所门诊药房的配药报销数据预测未来药房服务费：2006年至2012年国家健康保险数据库
BMC Health Serv Res. 2018 May 3;18(1):327. doi: 10.1186/s12913-018-3067-0.
引用本文的文献
1
The Cost of Oncology Drugs: A Pharmacy Perspective, Part 2.肿瘤药物的成本：药学视角，第二部分。
Fed Pract. 2016 Jul;33(7):35-39.
本文引用的文献
1
Strategic use of clinical pathways.临床路径的策略应用。
J Oncol Pract. 2011 Jan;7(1):54-6. doi: 10.1200/JOP.2010.000193.
2
What is a clinical pathway? Development of a definition to inform the debate.什么是临床路径？一个定义的发展，以提供信息的辩论。
BMC Med. 2010 May 27;8:31. doi: 10.1186/1741-7015-8-31.
3
American Society of Clinical Oncology guidance statement: the cost of cancer care.美国临床肿瘤学会指导声明：癌症护理的成本
J Clin Oncol. 2009 Aug 10;27(23):3868-74. doi: 10.1200/JCO.2009.23.1183. Epub 2009 Jul 6.
4
Access to affordable medications: the Department of Veterans Affairs pharmacy plan as a national model.获得可负担得起的药物：退伍军人事务部药房计划作为一个国家典范。
Am J Public Health. 2007 Dec;97(12):2129-31. doi: 10.2105/AJPH.2007.124008. Epub 2007 Oct 30.
5
The evolving use of cost-effectiveness analysis in formulary management within the Department of Veterans Affairs.退伍军人事务部内处方集管理中成本效益分析的应用演变
Med Care. 2005 Jul;43(7 Suppl):20-6. doi: 10.1097/01.mlr.0000170004.17480.49.
6
Pharmacy benefits management in the Veterans Health Administration: 1995 to 2003.退伍军人健康管理局的药房效益管理：1995年至2003年
Am J Manag Care. 2005 Feb;11(2):104-12.
7
Reducing clinical variations with clinical pathways: do pathways work?通过临床路径减少临床差异：路径有效吗？
Int J Qual Health Care. 2003 Dec;15(6):509-21. doi: 10.1093/intqhc/mzg057.
Zotero 插件